Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Pfizer”
Sponsor: Momentum Data
Inflammatory Bowel Diseases · Ulcerative Colitis · Crohn Disease
United Kingdom
Sponsor: Pfizer
Lyme Borreliosis
United States, Belgium, Germany
Sponsor: University of California, San Francisco
Metastatic Colon Adenocarcinoma · Metastatic Colorectal Adenocarcinoma · Metastatic Microsatellite Stable Colorectal Carcinoma · Metastatic Rectal Adenocarcinoma
United States
Sponsor: Liverpool School of Tropical Medicine
Streptococcus Pneumonia
United Kingdom
- A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart FailureCompleted
Sponsor: Pfizer
Diastolic Heart Failure
United States, Canada
Sponsor: University Hospital, Ghent
Acromegaly
Belgium
Sponsor: University Hospitals Cleveland Medical Center
Stroke · Brain Ischemia · Vasospasm, Intracranial · Hemorrhage, Intracranial
United States
Sponsor: BioNTech SE
SARS-CoV-2 Infection · COVID-19
United States
Sponsor: BioNTech SE
SARS-CoV-2 Infection · COVID-19
United States
- Predicting Successful Outcome of Interdisciplinary Biopsychosocial Rehabilitation in OsteoarthritisUnknown
Sponsor: Maastricht University
Chronic Pain · Osteoarthritis · Disability Physical
Netherlands
Sponsor: University of Calgary
Growth Hormone Treatment · Growth Hormone Deficiency · Concussion, Mild · Concussion Post Syndrome
- Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal CancerTerminated
Sponsor: M.D. Anderson Cancer Center
Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites · Malignant Neoplasms of Lip Oral Cavity and Pharynx · Oropharyngeal Cancer
United States
- The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataCompleted
Sponsor: Momentum Data
Alopecia Areata · Depressive Episode · Recurrent Depressive Disorder · Anxiety Disorders
United Kingdom
- Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2Completed
Sponsor: Pfizer
Pneumococcal Disease · COVID-19 · SARS-CoV-2 Infection
United States
Sponsor: Pfizer
Diabetes · Obesity
United States
Sponsor: Spondyloarthritis Research and Treatment Network
Spondyloarthritis
United States, Canada, Mexico
Sponsor: Universitaire Ziekenhuizen KU Leuven
Metastatic Breast Cancer
Belgium
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Bipolar Disorder · Schizophrenia
Sponsor: Pfizer
MRI Sedation
United States, Japan
Sponsor: Nova Scotia Health Authority
Cardiovascular Risk Reduction of Having a Coronary Event
Canada
Sponsor: Pfizer
Juvenile Idiopahtic Arthritis
Australia, Belgium, Colombia, Czechia, France +14 more
- Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's DiseaseCompleted
Sponsor: Pfizer
Alzheimer's Disease
United States, Australia, Belgium, Canada, South Korea +1 more
Sponsor: University of Oxford
Depression, Unipolar
United Kingdom
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Achondroplasia · Small for Gestational Age · Growth Hormone Deficiency
Germany
- LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial CancerTerminated
Sponsor: Wake Forest University Health Sciences
Urinary Bladder Neoplasms · Ureteral Neoplasms · Urethral Neoplasms
United States